Your dog was diagnosed with Insulinoma (Pancreatic Beta-Cell Tumour). Uncommon but clinically significant tumour. Presents with paraneoplastic hypoglycaemia (weakness, collapse, seizures). Most are malignant with metastatic potential to liver and regional lymph nodes. Compare 2 treatment options for dogs including Partial Pancreatectomy ± Metastasectomy, Medical Management (Diazoxide ± Prednisolone) — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Insulinoma (Pancreatic Beta-Cell Tumour)
Canine Oncology Treatment Guide
Insulinoma (Pancreatic Beta-Cell Tumour)
Stage I (pancreas only) to Stage III (metastatic)
Neuroendocrine
About This Cancer
Insulinoma is a tumour of the insulin-producing beta cells of the pancreas. Because the tumour cells retain the ability to secrete insulin — often in excess and without the normal regulatory controls — the hallmark of this cancer is dangerously low blood sugar (hypoglycaemia). Affected dogs may show weakness, disorientation, trembling, or even seizures, particularly after fasting or exercise. The symptoms can be intermittent, as insulin release from the tumour may fluctuate. Most insulinomas are malignant, though they tend to be slow-growing. Spread is most commonly to the liver and regional lymph nodes. Surgical removal of the tumour can provide significant benefit, and medical management with dietary changes and medications that counter insulin's effects can help maintain stable blood sugar levels. German Shepherds, Irish Setters, and Golden Retrievers are among the breeds at higher risk.
Modified clinical staging for canine insulinoma
Based on extent of disease at surgery
Prognostic Factors(2)
Minimum Workup(5 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.